Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Diabet Med. 2019 Jul 25;36(10):1282–1286. doi: 10.1111/dme.14069

Table 3.

Participant characteristics by age group and autism spectrum disorder status

<13 years ≥13 years
Autism spectrum disorder (n = 57) No autism spectrum disorder (n = 4097) Autism spectrum disorder (n = 102) No autism spectrum disorder (n = 5776)
Age (years); median (Q1, Q3) 10 (8, 12) 10 (7, 11) 16 (14, 17) 15 (14, 16)
Type 1 diabetes duration (years); median (Q1, Q3) 5 (4, 8) 5 (3, 7) 8 (6, 10) 8 (6, 11)
Pump use; n (%) 33 (59) 2611 (65) 48 (48) 3509 (62)
CGM use; n (%) 21 (38) 1364 (35) 17 (17) 1163 (21)
HbA1c; median (Q1, Q3)
 HbA1c (mmol/mol) 66 (56, 76) 67 (60, 76) 69 (63, 80) 73 (63, 87)
 HbA1c (%) 8.2 (7.3, 9.1) 8.3 (7.6, 9.1) 8.5 (7.9, 9.5) 8.8 (7.9, 10.1)
Blood glucose checks/day; median (Q1, Q3) 5.0 (4.0, 7.0) 5.0 (4.0, 7.0) 4.0 (3.0, 5.0) 4.0 (2.0, 5.0)
Total cholesterol (mmol/mol); mean (sd) 3.95 (20) 166 (28) 158 (28) 169 (37)
Total daily insulin per kg; mean (sd) 0.8 (0.4) 0.8 (0.3) 1.0 (0.3) 0.9 (0.3)